NFATC2 and pulmonary arterial hypertension: A chemical treatment (Plumbagin), which inhibits NFATc2 gene expression and NFATc2 nuclear localization, resulted in decreased cell proliferation of PASMCs derived from PAH patients, suggesting a positive relationship between NFATc2 signaling and cell proliferation of PASMCs in PAH27.